Treace Medical Concepts, Inc. (TMCI) earnings
TMCI earnings moved a median of +0.68% by the close. Quarterly and annual TMCI reports and results, each read against the price at its own news timestamp. Back to the TMCI overview →
29 measured TMCI earnings events.
Where these TMCI earnings landedvs 29 measured TMCI earnings reactions
| Middle 50% of TMCI earnings reactions | -3.79% to +8.06% |
|---|---|
| Median reaction (to close) | +0.68% |
| Measured reactions | 29 |
Point-in-time · zero look-ahead
Half of the 29 TMCI earnings events with a measured close landed between -3.79% and +8.06%; 62% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30 | SEC filing · Form 10-Q | -9.07% | -6.11% | |
| Treace Medical Concepts Reports Second Quarter 2026 Financial Results | Press release | -9.07% | -6.11% | |
| Treace to Report Second Quarter 2026 Financial Results on August 7, 2026 | Press release | +0.00% | -2.44% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31 | SEC filing · Form 10-Q | +3.79% | -4.74% | |
| Treace Medical Concepts Reports First Quarter 2026 Financial Results | Press release | +3.79% | -4.74% | |
| Treace to Report First Quarter 2026 Financial Results on May 8, 2026 | Press release | -0.55% | +9.39% | |
| Form 10-K TREACE MEDICAL CONCEPTS, For: Dec 31 | SEC filing · Form 10-K | -2.10% | -13.08% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Sep 30 | SEC filing · Form 10-Q | -5.13% | +14.49% | |
| Treace Medical Concepts Reports Third Quarter 2025 Financial Results | Press release | -5.13% | +14.49% | |
| Treace to Report Third Quarter 2025 Financial Results on November 6, 2025 | Press release | +0.00% | +0.15% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30 | SEC filing · Form 10-Q | +3.94% | +12.27% | |
| Treace Medical Concepts Reports Second Quarter 2025 Financial Results | Press release | +3.94% | +12.27% | |
| Treace to Report Second Quarter 2025 Financial Results on August 7, 2025 | Press release | -0.52% | -2.23% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31 | SEC filing · Form 10-Q | -5.15% | +0.29% | |
| Treace Medical Concepts Reports First Quarter 2025 Financial Results | Press release | -5.15% | +0.29% | |
| Treace to Report First Quarter 2025 Financial Results on May 8, 2025 | Press release | +1.44% | +2.13% | |
| Form 10-K TREACE MEDICAL CONCEPTS, For: Dec 31 | SEC filing · Form 10-K | -7.32% | +0.68% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Sep 30 | SEC filing · Form 10-Q | -1.69% | +8.06% | |
| Treace Medical Concepts Reports Third Quarter 2024 Financial Results | Press release | -1.69% | +8.06% | |
| Treace to Report Third Quarter 2024 Financial Results on November 5, 2024 | Press release | -0.19% | -3.79% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Jun 30 | SEC filing · Form 10-Q | -5.89% | +0.78% | |
| Treace Medical Concepts Reports Second Quarter 2024 Financial Results | Press release | -5.89% | +0.78% | |
| Treace to Report Second Quarter 2024 Financial Results on August 6, 2024 | Press release | +0.51% | +0.00% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Mar 31 | SEC filing · Form 10-Q | -1.78% | -7.33% | |
| Treace Medical Concepts Reports First Quarter 2024 Financial Results | Press release | -1.78% | -7.33% | |
| Treace to Report First Quarter 2024 Financial Results | Press release | -0.24% | +0.81% | |
| Form 10-K TREACE MEDICAL CONCEPTS, For: Dec 31 | SEC filing · Form 10-K | +7.22% | +6.96% | |
| Form 10-Q TREACE MEDICAL CONCEPTS, For: Sep 30 | SEC filing · Form 10-Q | +18.98% | +17.84% | |
| Treace Medical Concepts Reports Third Quarter 2023 Financial Results | Press release | +18.98% | +17.84% |
Keep exploring
More TMCI: analyst actions → · SEC filings → · TMCI overview →